Nifty

:

25285.35

Sensex

:

82500.82

103.55 (0.41%)
328.72 (0.40%)

Login

Nifty
Sensex

:
:

25285.35
82500.82

103.55 (0.41%)
328.72 (0.40%)

Valiant Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

44/99

BSE: 543998 | NSE: VALIANTLAB

Watchlist

NSE BSE

88.41

09-Oct-2025

Open
High
Low
Previous Close

81.75
89.8
80.96
81.74

Volume
Traded Value (lacs)
52 Week High
52 Week Low

128264
10980905.48
120.92
69.84

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

478.49
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

523.71
N/A
1.51

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-26.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 51.01 18.88 170.18% 57.77 30.58 88.91% 35.23 40.52 -13.06% 21.48 59.55 -63.93%
Expenses 48.64 21.27 128.68% 53.94 35.11 53.63% 34.61 46.82 -26.08% 28.22 60.93 -53.68%
EBITDA 2.36 -2.39 - 3.83 -4.53 - 0.62 -6.31 - -6.74 -1.39 -
EBIDTM 4.63% -12.65% 6.63% -14.81% 1.77% -15.57% -31.38% -2.33%
Other Income 0.67 2.17 -69.12% 0.65 2.50 -74.00% 0.67 1.77 -62.15% 1.93 2.96 -34.80%
Interest 0.07 0.05 40.00% 0.06 0.02 200.00% 0.06 0.02 200.00% 0.01 0.02 -50.00%
Depreciation 0.51 0.50 2.00% 0.51 0.50 2.00% 0.51 0.49 4.08% 0.51 0.49 4.08%
PBT 2.45 -0.77 - 3.92 -2.55 - 0.72 -5.04 - -5.32 1.06 -
Tax 0.63 0.23 173.91% 0.69 -1.33 - -0.88 -1.54 - 0.66 0.27 144.44%
PAT 1.82 -1.01 - 3.24 -1.22 - 1.60 -3.50 - -5.98 0.79 -
PATM 3.56% -5.32% 5.61% -3.98% 4.54% -8.65% -27.86% 1.33%
EPS 0.42 -0.23 - 0.75 -0.28 - 0.37 -0.81 - -1.38 0.18 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 46.82 18.88 147.99% 57.79 30.59 88.92% 35.23 40.52 -13.06% 21.48 59.55 -63.93%
Expenses 44.42 21.27 108.84% 53.96 35.12 53.64% 34.61 46.82 -26.08% 28.22 60.93 -53.68%
EBITDA 2.40 -2.39 - 3.83 -4.53 - 0.62 -6.31 - -6.74 -1.39 -
EBIDTM 5.13% -12.65% 6.62% -14.81% 1.77% -15.57% -31.38% -2.33%
Other Income 0.66 2.81 -76.51% -2.31 2.50 - 1.58 1.77 -10.73% 3.36 2.96 13.51%
Interest 0.07 0.05 40.00% 0.06 0.02 200.00% 0.06 0.02 200.00% 0.01 0.02 -50.00%
Depreciation 0.53 0.53 0.00% 0.52 0.52 0.00% 0.52 0.49 6.12% 0.52 0.49 6.12%
PBT 2.45 -0.16 - 0.94 -2.57 - 1.62 -5.04 - -3.91 1.06 -
Tax 0.63 0.35 80.00% 0.24 -1.33 - -0.73 -1.54 - 0.83 0.27 207.41%
PAT 1.82 -0.51 - 0.70 -1.24 - 2.34 -3.50 - -4.74 0.79 -
PATM 3.89% -2.70% 1.22% -4.05% 6.65% -8.65% -22.08% 1.33%
EPS 0.39 -0.11 - 0.15 -0.26 - 0.50 -0.75 - -1.01 0.23 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales 165.49 133.36 182.05 333.91 291.52 Net Sales Growth 10.67% -26.75% -45.48% 14.54% Cost Of Goods Sold 141.48 116.05 167.52 276.52 234.22 Gross Profit 24.01 17.32 14.52 57.39 57.30 GP Margin 14.51% 12.99% 7.98% 17.19% 19.66% Total Expenditure 165.41 138.05 190.46 298.84 249.21 Power & Fuel Cost - 5.94 8.33 7.37 4.38 % Of Sales - 4.45% 4.58% 2.21% 1.50% Employee Cost - 4.39 4.31 4.61 3.06 % Of Sales - 3.29% 2.37% 1.38% 1.05% Manufacturing Exp. - 3.78 6.15 5.13 3.93 % Of Sales - 2.83% 3.38% 1.54% 1.35% General & Admin Exp. - 0.84 0.78 0.90 0.53 % Of Sales - 0.63% 0.43% 0.27% 0.18% Selling & Distn. Exp. - 1.82 2.00 2.97 2.03 % Of Sales - 1.36% 1.10% 0.89% 0.70% Miscellaneous Exp. - 5.24 1.37 1.34 1.06 % Of Sales - 3.93% 0.75% 0.40% 0.36% EBITDA 0.07 -4.69 -8.41 35.07 42.31 EBITDA Margin 0.04% -3.52% -4.62% 10.50% 14.51% Other Income 3.92 5.44 9.68 4.89 1.95 Interest 0.20 0.18 0.08 0.25 0.07 Depreciation 2.04 2.02 1.95 1.56 2.49 PBT 1.77 -1.45 -0.75 38.14 41.70 Tax 1.10 0.70 -1.09 9.14 14.21 Tax Rate 62.15% -48.28% 145.33% 23.96% 34.08% PAT 0.68 -2.15 0.34 29.00 27.50 PAT before Minority Interest 0.68 -2.15 0.34 29.00 27.50 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.41% -1.61% 0.19% 8.68% 9.43% PAT Growth 113.77% - -98.83% 5.45% EPS 0.16 -0.50 0.08 6.68 6.34

Description TTM Mar 25 Mar 24 Mar 23
Net Sales 161.32 133.38 182.06 333.91 Net Sales Growth 7.88% -26.74% -45.48% Cost Of Goods Sold 137.26 116.06 167.53 276.52 Gross Profit 24.06 17.32 14.53 57.39 GP Margin 14.91% 12.99% 7.98% 17.19% Total Expenditure 161.21 138.08 190.47 298.84 Power & Fuel Cost - 5.94 8.33 7.37 % Of Sales - 4.45% 4.58% 2.21% Employee Cost - 4.39 4.31 4.61 % Of Sales - 3.29% 2.37% 1.38% Manufacturing Exp. - 3.78 6.15 5.13 % Of Sales - 2.83% 3.38% 1.54% General & Admin Exp. - 0.84 0.78 0.90 % Of Sales - 0.63% 0.43% 0.27% Selling & Distn. Exp. - 1.82 2.00 2.97 % Of Sales - 1.36% 1.10% 0.89% Miscellaneous Exp. - 5.24 1.37 1.34 % Of Sales - 3.93% 0.75% 0.40% EBITDA 0.11 -4.70 -8.41 35.07 EBITDA Margin 0.07% -3.52% -4.62% 10.50% Other Income 3.29 5.45 9.68 4.89 Interest 0.20 0.18 0.08 0.25 Depreciation 2.09 2.09 1.97 1.56 PBT 1.10 -1.51 -0.77 38.14 Tax 0.97 0.69 -1.09 9.14 Tax Rate 88.18% -45.70% 141.56% 23.96% PAT 0.12 -2.20 0.32 29.00 PAT before Minority Interest 0.12 -2.20 0.32 29.00 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 0.07% -1.65% 0.18% 8.68% PAT Growth 102.69% - -98.90% EPS 0.03 -0.51 0.07 6.68

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 234.38 236.88 100.49 71.46 Share Capital 43.45 43.45 32.56 16.28 Total Reserves 190.93 193.43 67.93 55.18 Non-Current Liabilities 61.95 61.48 61.75 60.92 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 59.40 59.40 59.40 59.40 Long Term Provisions 0.09 0.08 0.08 0.00 Current Liabilities 20.95 26.36 50.52 49.43 Trade Payables 19.40 24.76 47.30 46.44 Other Current Liabilities 1.41 1.48 3.10 1.55 Short Term Borrowings 0.00 0.00 0.00 1.28 Short Term Provisions 0.14 0.12 0.12 0.16 Total Liabilities 317.28 324.72 212.76 181.81 Net Block 30.02 31.61 29.97 22.23 Gross Block 42.77 42.35 38.76 29.75 Accumulated Depreciation 12.75 10.74 8.79 7.53 Non Current Assets 198.06 115.46 30.80 25.01 Capital Work in Progress 0.17 0.22 0.05 1.45 Non Current Investment 165.06 80.97 0.01 0.00 Long Term Loans & Adv. 2.82 2.66 0.77 1.34 Other Non Current Assets 0.00 0.00 0.00 0.00 Current Assets 119.22 209.27 181.96 156.80 Current Investments 0.00 37.61 34.02 0.40 Inventories 3.96 10.02 13.04 15.80 Sundry Debtors 72.10 45.72 88.57 110.77 Cash & Bank 27.34 96.72 0.46 20.13 Other Current Assets 15.82 2.01 1.24 0.88 Short Term Loans & Adv. 15.42 17.19 44.64 8.81 Net Current Assets 98.27 182.90 131.44 107.37 Total Assets 317.28 324.73 212.76 181.81

Description Mar 25 Mar 24 Mar 23
Shareholder's Funds 234.31 236.86 100.49 Share Capital 43.45 43.45 32.56 Total Reserves 190.86 193.41 67.93 Non-Current Liabilities 106.93 76.75 61.75 Secured Loans 44.95 15.26 0.00 Unsecured Loans 59.40 59.40 59.40 Long Term Provisions 0.13 0.08 0.08 Current Liabilities 59.62 29.08 50.73 Trade Payables 40.72 25.93 47.30 Other Current Liabilities 1.84 1.65 3.31 Short Term Borrowings 16.86 1.39 0.00 Short Term Provisions 0.20 0.12 0.12 Total Liabilities 400.86 342.69 212.97 Net Block 48.44 50.05 48.12 Gross Block 70.67 70.21 66.31 Accumulated Depreciation 22.23 20.16 18.19 Non Current Assets 208.24 117.14 62.39 Capital Work in Progress 155.78 42.65 0.68 Non Current Investment 0.00 0.00 0.00 Long Term Loans & Adv. 4.02 24.44 13.59 Other Non Current Assets 0.00 0.00 0.00 Current Assets 192.62 225.54 150.58 Current Investments 0.00 37.61 34.02 Inventories 3.99 10.02 13.04 Sundry Debtors 72.12 45.73 88.57 Cash & Bank 75.99 106.21 1.34 Other Current Assets 40.52 2.02 1.24 Short Term Loans & Adv. 39.71 23.96 12.37 Net Current Assets 133.00 196.47 99.85 Total Assets 400.86 342.68 212.97

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity -21.90 48.78 22.96 2.25 PBT -1.45 -0.75 38.14 41.70 Adjustment 4.22 2.03 1.82 3.06 Changes in Working Capital -27.86 46.53 -8.20 -28.05 Cash after chg. in Working capital -25.09 47.80 31.76 16.72 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid 3.19 0.98 -8.80 -14.47 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity 24.97 -182.73 -21.18 -12.24 Net Fixed Assets -0.37 -3.76 -7.61 Net Investments -46.48 -84.55 -33.63 Others 71.82 -94.42 20.06 Cash from Financing Activity -0.50 135.80 -1.53 6.18 Net Cash Inflow / Outflow 2.57 1.85 0.24 -3.81 Opening Cash & Equivalents 2.23 0.38 0.13 3.94 Closing Cash & Equivalent 4.80 2.23 0.38 0.13

Description Mar 25 Mar 24 Mar 23
Cash From Operating Activity 1.31 1.89 56.05 PBT -1.51 -0.77 38.14 Adjustment 4.29 2.04 1.56 Changes in Working Capital -3.93 -0.37 25.16 Cash after chg. in Working capital -1.15 0.90 64.85 Interest Paid 0.00 0.00 0.00 Tax Paid 2.47 0.98 -8.80 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -52.77 -143.88 -55.17 Net Fixed Assets -0.37 -3.76 Net Investments -46.48 -84.55 Others -5.92 -55.57 Cash from Financing Activity 44.65 152.45 -0.93 Net Cash Inflow / Outflow -6.80 10.46 -0.05 Opening Cash & Equivalents 11.72 1.26 1.31 Closing Cash & Equivalent 4.92 11.72 1.26

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 50.07 50.60 30.86 21.95 ROA -0.67% 0.13% 14.70% 15.12% ROE -0.91% 0.20% 33.73% 38.48% ROCE -0.43% -0.30% 26.29% 31.62% Fixed Asset Turnover 3.13 4.49 9.75 9.80 Receivable days 161.23 134.62 108.95 138.69 Inventory Days 19.12 23.11 15.77 19.79 Payable days 69.46 78.50 61.86 72.37 Cash Conversion Cycle 110.90 79.23 62.85 86.11 Total Debt/Equity 0.25 0.25 0.59 0.85 Interest Cover -7.26 -8.67 151.32 572.29

Description Mar 25 Mar 24 Mar 23
Book Value (Rs.) 50.05 50.60 30.86 ROA -0.59% 0.12% 13.62% ROE -0.93% 0.19% 28.86% ROCE -0.40% -0.29% 24.01% Fixed Asset Turnover 1.89 2.67 5.04 Receivable days 161.25 134.62 96.82 Inventory Days 19.16 23.11 14.26 Payable days 104.79 79.77 62.43 Cash Conversion Cycle 75.62 77.97 48.64 Total Debt/Equity 0.52 0.32 0.59 Interest Cover -7.63 -8.89 151.32

Top Investors:

money logix securities private limited

l7 hitech private limited

dhirajbhai vaghjibhai koradiya

Annual Reports:

News Update:

Valiant Laboratories - Quarterly Results
8th Aug 2025, 16:49 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback